Is Booking Holdings Stock Undervalued?
There is a lot of humdrum in the market about…
Sell
34
EXPO Quote, Financials, Valuation and Earnings
Last price:
$87.83
Seasonality move
:
4.44%
Day range:
$88.62 - $90.21
52-week range:
$68.70 - $115.75
Dividend yield:
1.26%
P/E ratio:
43.04x
P/S ratio:
8.43x
P/B ratio:
11.02x
Volume:
155.4K
Avg. volume:
235.4K
1-year change:
1.2%
Market cap:
$4.5B
Revenue:
$536.8M
EPS (TTM):
$2.07
Analysts' Opinion
-
Consensus RatingExponent has received a consensus rating of Hold. The company's average rating is a Hold based on 1 Buy rating, 2 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of --, Exponent has an estimated upside of 30.19% from its current price of $89.10.
-
Price Target DownsideAccording to analysts, the lowest downside price target is -- representing 100% downside risk from its current price of $89.10.
Fair Value
-
According to the consensus of 3 analysts, Exponent has 30.19% upside to fair value with a price target of -- per share.
EXPO vs. S&P 500
-
Over the past 5 trading days, Exponent has overperformed the S&P 500 by 2.28% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Exponent does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Exponent has grown year-over-year revenues for 3 quarters straight. In the most recent quarter Exponent reported revenues of $136.3M.
Earnings Growth
-
Exponent has grown year-over-year earnings for 3 quarters straight. In the most recent quarter Exponent reported earnings per share of $0.50.
Enterprise value:
4.3B
EV / Invested capital:
--
Price / LTM sales:
8.43x
EV / EBIT:
38.88x
EV / Revenue:
7.90x
PEG ratio (5yr expected):
9.47x
EV / Free cash flow:
28.03x
Price / Operating cash flow:
29.90x
Enterprise value / EBITDA:
35.78x
Gross Profit (TTM):
--
Return On Assets:
15.96%
Net Income Margin (TTM):
19.53%
Return On Equity:
28.17%
Return On Invested Capital:
28.17%
Operating Margin:
18.97%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $499.4M | $541.2M | $544.6M | $133.3M | $136.3M | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | $142.2M | $115M | $110.7M | $33.9M | $25.8M | |
| EBITDA | $149M | $123.4M | $120.3M | $36.3M | $28.2M | |
| Diluted EPS | $1.90 | $1.98 | $2.07 | $0.48 | $0.50 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $328.6M | $417.6M | $332.5M | $343.3M | $412.6M | |
| Total Assets | $534.7M | $638.3M | $559M | $602.5M | $744.1M | |
| Current Liabilities | $96.4M | $126.4M | $137.9M | $129.7M | $137.7M | |
| Total Liabilities | $191.5M | $233.3M | $239.2M | $248.8M | $333.8M | |
| Total Equity | $343.2M | $405M | $319.8M | $353.6M | $410.3M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $107.4M | $96.6M | $159.8M | $22.2M | $29.7M | |
| Cash From Investing | $14.5M | -$17.4M | -$6.3M | -$3.3M | -$1.7M | |
| Cash From Financing | -$200.5M | -$91.4M | -$72.8M | -$29.6M | -$13M | |
| Free Cash Flow | $96.9M | $79.3M | $153.5M | $18.9M | $28M | |
EXPO
Sector
Market Cap
$4.5B
$764.1M
Price % of 52-Week High
76.98%
78.46%
Dividend Yield
1.26%
0%
Shareholder Yield
1.18%
2.32%
1-Year Price Total Return
1.2%
-1.97%
Beta (5-Year)
0.707
0.918
Dividend yield:
1.26%
Annualized payout:
$1.04
Payout ratio:
53.73%
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$89.95
200-day SMA
Sell
Level
$97.57
Bollinger Bands (100)
Sell
Level
95.58 - 110.22
Chaikin Money Flow
Buy
Level
34.4M
20-day SMA
Sell
Level
$93.07
Relative Strength Index (RSI14)
Sell
Level
30.38
ADX Line
Sell
Level
31.05
Williams %R
Buy
Level
-86.7073
50-day SMA
Sell
Level
$97.25
MACD (12, 26)
Sell
Level
-2.63
25-day Aroon Oscillator
Sell
Level
-92
On Balance Volume
Neutral
Level
41.6M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (12.2343)
Buy
CA Score
(Annual)
Level (0.9141)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (8)
Buy
Ohlson Score
Level (-1.1901)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Exponent Inc provides engineering and scientific consulting services on a project-by-project basis. The company's consultant team is composed of scientists, physicians, engineers, as well as business and regulatory consultants. The company currently operates through two segments. The engineering and other scientific segments, which accounts for the majority of revenue, provides servicing encompassing biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, etc. The environmental and health segment covers chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences and others. The company generates almost all of its revenues from America.
Stock Forecast FAQ
In the current month, EXPO has received 1 Buy ratings 2 Hold ratings, and 0 Sell ratings. The EXPO average analyst price target in the past 3 months is --.
-
Where Will Exponent Stock Be In 1 Year?
According to analysts, the consensus estimate is that Exponent share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Exponent?
Analysts are divided on their view about Exponent share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Exponent is a Sell and believe this share price will drop from its current level to --.
-
What Is Exponent's Price Target?
The price target for Exponent over the next 1-year time period is forecast to be -- according to 3 Wall Street analysts, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.
-
Is EXPO A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Exponent is a Hold. 2 of 3 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of EXPO?
You can purchase shares of Exponent via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Exponent shares.
-
What Is The Exponent Share Price Today?
Exponent was last trading at $87.83 per share. This represents the most recent stock quote for Exponent. Yesterday, Exponent closed at $89.10 per share.
-
How To Buy Exponent Stock Online?
In order to purchase Exponent stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Broadcom vs American Express: Which Is Best?
Chip giant Broadcom Inc. (NASDAQ:AVGO) and card company American Express…
Why Is Adobe Stock Dropping?
Why is Adobe stock dropping? A combination of underwhelming fiscal…
Stock Ideas
Buy
58
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 41x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Sell
48
Is MSFT Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 36x
Alerts
Sell
25
DRUG alert for Jan 2
Bright Minds Biosciences [DRUG] is up 13.55% over the past day.
Buy
56
QMCO alert for Jan 2
Quantum [QMCO] is up 0.83% over the past day.
Buy
78
BMA alert for Jan 2
Banco Macro SA [BMA] is up 12.94% over the past day.
